Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... not eligible for, or opted not to participate in allogenic stem cell transplantation h. Off all other treatments for MDS (including ... of >30%) d.         Suitable candidate to receive allogeneic stem cell transplantation; patient is eligible for study if a ...

    Clinical Trial last updated 05/04/2018 - 3:53pm.

  2. Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (CHAMP)

    ... (OS) separately in the 2 arms at 1 year post-hematopoietic stem cell transplantation (HSCT). ... (MFI) > 1000 by solid phase immunoassay). Prior allogeneic stem cell transplant . Prior solid organ transplant. ...

    Clinical Trial last updated 12/19/2017 - 7:55am.

  3. Haploidentical transplant in patients with myelodysplastic syndrome

    ... intermediate or high-risk myelodysplastic syndrome (MDS) is allogeneic hematopoietic stem cell transplantation (HSCT), which usually results in a long-term, ...

    Research Article last updated 10/04/2017 - 9:19am.

  4. First-in Human Clinical Transplant Trial for Severe Aplastic Anemia

    ... How did the idea to study a particular type of stem cell transplant originate? The idea for the study in question is ... of prior research that was focused on ways to offer safe allogeneic stem cell transplants using alternative donors for patients who lack ...

    Interview last updated 10/04/2017 - 1:36pm.

  5. Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future

    ... outcome of current and emerging strategies of TCD in allogeneic hematopoietic stem cell transplant that have developed during the modern transplantation ...

    Research Article last updated 09/14/2017 - 8:49am.

  6. Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience

    ... there was no survival difference between IST and allogeneic stem cell transplant groups, with trend towards superior OS in the former. ...

    Research Article last updated 09/13/2017 - 7:40am.

  7. Explaining SCT vs. Cellular Therapies

    ... Article Link:  Stem Cell Transplants and Cellular Therapies: What’s the Difference? ... of that therapy. When donor stem cells are used – an allogeneic transplant – the chemotherapy and radiation therapy may have some ...

    Article last updated 09/08/2017 - 12:41pm.

  8. Allogeneic transplant: does age still matter?

    ... Article Link:  Allogeneic transplant: does age still matter? ... et al report on the incidence and outcome of allogeneic stem cell transplantations (alloSCTs) performed between 2000 and 2013 in 1106 ...

    Article last updated 08/31/2017 - 2:17pm.

  9. Making Progress for Myelodysplastic Syndromes

    ... we tailor therapy based on that, such as recommending allogeneic stem cell transplant for patients. An accurate risk assessment for the ...

    Article last updated 07/26/2017 - 10:25am.

  10. CASCADE (SGN33A-005)

    ... or t(15;17) Patients who are candidates for allogeneic stem cell transplant at the time of enrollment Patients with a history ...

    Clinical Trial last updated 06/19/2017 - 2:43pm.